Artera Receives Frost & Sullivan Recognition for AI Breast Cancer Risk Stratification
Frost & Sullivan recognized Artera for its AI-powered breast cancer risk stratification technology. The recognition highlights Artera’s clinical evidence and role in precision oncology.